开创我国先天性红细胞疾病分子诊断新局面

李园

doi:10.13201/j.issn.1004-2806.2020.11.001

开创我国先天性红细胞疾病分子诊断新局面

李园^1,2, ,

- 1. 中国医学科学院北京协和医学院血液学研究所血液病医院贫血诊疗中心(天津, 300020);
- 2. 中国医学科学院北京协和医学院血液学研究所血液病医院实验血液学国家重点实验室
基金项目:
科技部国家科技重大专项(No:2017ZX09304024)

详细信息

通讯作者: 李园,E-mail:liyuan@ihcams.ac.cn

中图分类号: R555.1

收稿日期: 2020-09-25

To create a new scenario in the molecular diagnosis of congenital red blood cell disorders in China

LI Yuan^1,2, ,

More Information

Corresponding author: LI Yuan, E-mail: liyuan@ihcams.ac.cn

Received Date: 25 September 2020

摘要

- 先天性 /
- 红细胞 /
- 贫血 /
- 红细胞增多症 /
- 分子诊断 /
- 二代基因测序技术 /
- 基因
- congenital /
- erythrocyte /
- anemia /
- erythrocytosis /
- genetic diagnosis /
- next generation sequencing /
- gene

HTML全文

参考文献(44)

[1]	Schneider M,Chandler K,Tischkowitz M,et al.Fanconi anaemia:genetics,molecular biology,and cancer-implications for clinical management in children and adults[J].Clin Genet,2015,88:13-24.
[2]	Levy SE,Myers RM.Advancements in Next-Generation Sequencing[J].Annu Rev Genomics Hum Genet,2016,17:95-115.
[3]	Beck TF,Mullikin JC,NISC Comparative Sequencing Program,et al.Systematic Evaluation of Sanger Validation of Next-Generation Sequencing Variants[J].Clin Chem,2016,62:647-654.
[4]	Rehm HL,Bale SJ,Bayrak-Toydemir P,et al.ACMG clinical laboratory standards for next-generation sequencing[J].Genet Med,2013,15:733-747.
[5]	Richards S,Aziz N,Bale S,et al.Standards and guidelines for the interpretation of sequence variants:a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J].Genet Med,2015,17:405-424.
[6]	孙隽,黄颐,王小冬,等.遗传病二代测序临床检测全流程规范化共识探讨(3)--数据分析流程[J].中华医学遗传学杂志,2020,37(3):345-351.
[7]	李园,彭广新,高清妍,等.应用靶向二代测序诊断疑诊先天性贫血46例[J].中华血液学杂志,2018,39(5):414-419.
[8]	ACMG Board of Directors.Points to consider in the clinical application of genomic sequencing[J].Genet Med,2012,14:759-761.
[9]	Adams DR,Eng CM.Next-Generation Sequencing to Diagnose Suspected Genetic Disorders[J].N Engl J Med,2019,380:201.
[10]	Consugar MB,Navarro-Gomez D,Place EM,et al.Panel-based genetic diagnostic testing for inherited eye diseases is highly accurate and reproducible,and more sensitive for variant detection,than exome sequencing[J].Genet Med,2015,17:253-261.
[11]	Dillon OJ,Lunke S,Stark Z,et al.Exome sequencing has higher diagnostic yield compared to simulated disease-specific panels in children with suspected monogenic disorders[J].Eur J Hum Genet,2018,26:644-651.
[12]	Lionel AC,Costain G,Monfared N,et al.Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test[J].Genet Med,2018,20:435-443.
[13]	Sun Y,Ruivenkamp CA,Hoffer MJ,et al.Next-generation diagnostics:gene panel,exome,or whole genome?[J].Hum Mutat,2015,36:648-655.
[14]	Alfares A,Aloraini T,Subaie LA,et al.Whole-genome sequencing offers additional but limited clinical utility compared with reanalysis of whole-exome sequencing[J].Genet Med,2018,20:1328-1333.
[15]	Ghemlas I,Li H,Zlateska B,et al.Improving diagnostic precision,care and syndrome definitions using comprehensive next-generation sequencing for the inherited bone marrow failure syndromes[J].J Med Genet,2015,52:575-584.
[16]	Roy NB,Wilson EA,Henderson S,et al.A novel 33-Gene targeted resequencing panel provides accurate,clinical-grade diagnosis and improves patient management for rare inherited anaemias[J].Br J Haematol,2016,175:318-330.
[17]	Russo R,Andolfo I,Iolascon A.Next generation research and therapy in red blood cell diseases[J].Haematologica,2016,101:515-517.
[18]	Shefer Averbuch N,Steinberg-Shemer O,Dgany O,et al.Targeted next generation sequencing for the diagnosis of patients with rare congenital anemias[J].Eur J Haematol,2018,101:297-304.
[19]	Kedar PS,Harigae H,Ito E,et al.Study of pathophysiology and molecular characterization of congenital anemia in India using targeted next-generation sequencing approach[J].Int J Hematol,2019,110:618-626.
[20]	Agarwal AM,Nussenzveig RH,Reading NS,et al.Clinical utility of next-generation sequencing in the diagnosis of hereditary haemolytic anaemias[J].Br J Haematol,2016,174:806-814.
[21]	Mansour-Hendili L,Aissat A,Badaoui B,et al.Exome sequencing for diagnosis of congenital hemolytic anemia[J].Orphanet J Rare Dis,2020,15:180.
[22]	Camps C,Petousi N,Bento C,et al.Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations[J].Haematologica,2016,101:1306-1318.
[23]	Moreno-Carralero MI,Horta-Herrera S,Morado-Arias M,et al.Clinical and genetic features of congenital dyserythropoietic anemia (CDA)[J].Eur J Haematol,2018,101:368-378.
[24]	彭广新,杨文睿,赵馨,等. 37例遗传性球形细胞增多症基因突变特征分析[J].中华血液学杂志,2018,39(11):898-903.
[25]	An W,Zhang J,Chang L,et al.Mutation analysis of Chinese sporadic congenital sideroblastic anemia by targeted capture sequencing[J].J Hematol Oncol,2015,8:55.
[26]	Li Y,Li Y,Yang Y,et al.Next generation sequencing reveals co-existence of hereditary spherocytosis and Dubin-Johnson syndrome in a Chinese gril:A case report[J].World J Clin Cases,2019,7:3303-3309.
[27]	Kang LL,Liu ZL,Zhang HD.Gilbert's syndrome coexisting with hereditary spherocytosis might not be rare:Six case reports[J].World J Clin Cases,2020,8:2001-2008.
[28]	Fermo E,Vercellati C,Marcello AP,et al.Hereditary Xerocytosis due to Mutations in PIEZO1 Gene Associated with Heterozygous Pyruvate Kinase Deficiency and Beta-Thalassemia Trait in Two Unrelated Families[J].Case Rep Hematol,2017,2017:2769570.
[29]	Chao MM,Thomay K,Goehring G,et al.Mutational Spectrum of Fanconi Anemia Associated Myeloid Neoplasms[J].Klin Padiatr,2017,229:329-334.
[30]	DiNardo CD,Bannon SA,Routbort M,et al.Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC)[J].Clin Lymphoma Myeloma Leuk,2016,16:417-428.e2.
[31]	Przychodzen B,Makishima H,Sekeres MA,et al.Fanconi Anemia germline variants as susceptibility factors in aplastic anemia,MDS and AML[J].Oncotarget,2018,9:2050-2057.
[32]	安文彬,刘超,万扬,等.伴髓系恶性转化的Shwachman-Diamond综合征患儿的临床特征及基因突变分析[J].中国当代儿科杂志,2020,22(5):460-465.
[33]	Andolfo I,Russo R,Gambale A,et al.Hereditary Stomatocytosis:An underdiagnosed condition[J].Am J Hematol,2018,93:107-121.
[34]	王珂,党瑜慧,李芝兰,等.高通量测序技术筛检地中海贫血的临床意义[J].中国实验血液学杂志,2019,27(4):1220-1226.
[35]	Rivera A,Vandorpe DH,Shmukler BE,et al.Erythrocyte ion content and dehydration modulate maximal Gardos channel activity in KCNN4 V282M/+hereditary xerocytosis red cells[J].Am J Physiol Cell Physiol,2019,317:C287-C302.
[36]	Andolfo I,Alper SL,De Franceschi L,et al.Multiple clinical forms of dehydrated hereditary stomatocytosis arise from mutations in PIEZO1[J].Blood,2013,121:3925-3935,S1-S12.
[37]	Andolfo I,Russo R,Rosato BE,et al.Genotype-phenotype correlation and risk stratification in a cohort of 123 hereditary stomatocytosis patients[J].Am J Hematol,2018,93:1509-1517.
[38]	Qiu QW,Wu DD,Yu LH,et al.Evidence of recent natural selection on the Southeast Asian deletion (--(SEA)) causing alpha-thalassemia in South China[J].BMC Evol Biol,2013,13:63.
[39]	龚珠文,余永国,张其刚,等.应用第二代测序对一个范可尼贫血家系进行基因突变检测和产前诊断[J].中华医学遗传学杂志,2015,32(2):204-207.
[40]	Wu-Chou YH,Hung TC,Lin YT,et al.Genetic diagnosis of neurofibromatosis type 1:targeted next-generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis[J].J Biomed Sci,2018,25:72.
[41]	Weitzel KW,Alexander M,Bernhardt BA,et al.The IGNITE network:a model for genomic medicine implementation and research[J].BMC Med Genomics,2016,9:1.
[42]	Ewans LJ,Schofield D,Shrestha R,et al.Whole-exome sequencing reanalysis at 12 months boosts diagnosis and is cost-effective when applied early in Mendelian disorders[J].Genet Med,2018,20:1564-1574.
[43]	Volk AE,Kubisch C.The rapid evolution of molecular genetic diagnostics in neuromuscular diseases[J].Curr Opin Neurol,2017,30:523-528.
[44]	Barseghyan H,Tang W,Wang RT,et al.Next-generation mapping:a novel approach for detection of pathogenic structural variants with a potential utility in clinical diagnosis[J].Genome Med,2017,9:90.